Global Intragastric Balloon Market: Drivers, Opportunities, Trends and Forecast 2017-2023

  • Product Code:
  • Published Date:
    Mar 2019
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Infoholic Research
Global Intragastric Balloon Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Gastric balloon is a medical device that is used in an endoscopic intragastrical procedure, where the inflated silicone balloon is inserted in the stomach and is retained there for 6–12 months. This is widely known as weight loss balloon that is designed to help individuals to eat less and feel full sooner while eating. This makes less room for food and helps the body to adapt to healthy portions. This procedure is non-surgical, non-invasive, and requires no-incision. However, this procedure is not permanent and helps individual to lose up to three times the weight when compared to diet alone. Apart from weight loss it has many health benefits as it helps in improving diabetes, maintains cardiac health, and improves other bone-related issues.
Endoscopic bariatric therapies (EBT) have shown greater results and less adverse events. The delivery of EBT requires special room facility and preparation that will accommodate the size, weight, and surgical gowns for the patient.
The FDA approved products, such as Orbera intragastric balloon, the AspireAssist, and ReShape Integrated Dual Balloon have high signifiance in the market.
Intragastric balloon offers non-surgical and less invasive endoscopic procedure with reversible weight measurement that has grown in a scale with stronger impact on the market. Therefore, as more EBT are available for obese patients it will become more feasible and effective to offer long-term treatment in the future.
The major products in the market include:
• Orbera
• Spatz Adjustable Balloon system
• ReShape Duo Integrated DualBalloon System
• The Elipse
• Air-supplied Obalon Gastric Balloon
• Heliosphere BAG
The market is dominated by Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, which has more than 90% market share in the Global Intragastric Balloon market. Factors, such as the increased prevalence of obesity, growing popularity about minimally non-invasive techniques, and the introduction of swallowable pills, are expected to boost the market growth.
Market Analysis: The Global Intragastric Balloon Market is estimated to witness a CAGR of 9.6% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product type, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the intragastric balloon market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the number of obese population and its related chronic disorders. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of diseases. Medical tourism is the new trend in emerging markets as most of the people from developed countries are traveling to APAC, especially India, for bariatric procedures. However, the high cost of intragastric balloons and expensive procedural costs, lack of skilled surgeons, lack of proper reimbursement policies, lack of awareness about gastric balloons in developed and developing countries have significant impact on the overall market growth.
Product Analysis: Single intragastric balloon is growing at a steady rate and dominates the global intragastric balloon market with 55% of the total market share. Factors, such as the increasing obese population, rise in prevalence of chronic diseases, and rise in popularity of minimally non-invasive techniques, are driving the market growth. The is one of the first and well-known gastric balloon used since the introduction of intragastric balloons in the market. The popularity of single intragastric balloon for its non-invasive technique and alternative to undergo the knife has increased the adoption of gastric balloons in the market accounting for 50% of the total market share. Orbera by Apollo Endosurgery is one of the most popular single gastric balloon that received FDA clearance in August 2015. This product is also known as BIB (BioEnterics Intragastric Balloon). It is made of silicone and filled with saline after endoscopic transoral placement inside the patient’s stomach.
Key Players: Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players.
Competitive Analysis: The global intragastric balloon market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of gastric balloons, especially in the US, Canada, France, Germany, and the UK and few of the Middle East Countries. These countries have the highest obese population accounting to 70% to 75% of the total obese population worldwide. Major vendors are directly competing with primary bariatric invasive surgical companies for replacing surgeries such as sleeve gastrectomy, gastric bypass, and various laparoscopy surgeries. Most of the companies, including tier II companies also focus on building a strong relationship with the customers and physicians to have direct sales and product revenue generation. The growing awareness about the products and rise in number of physician-owned implant distributions that have resulted in the rise in volume of intragastric balloon procedures have led individuals undergo treatment for obesity.
Benefits: The report provides complete details about the usage and adoption rate of intragastric balloons for the treatment of obesity. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the intragastric balloon adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Emerging Global Markets 9
1.3 Weight related disorders 10
1.4 Industry Trends 11
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 14
3.1 Total Addressable Market (TAM) 14
3.2 Segmented Addressable Market (SAM) 15
3.2.1 Definition 15
3.2.2 Importance of intragastric balloon 15
3.2.3 Single Intragastric Balloon 16
3.2.4 Dual Intragastric Balloon 16
3.2.5 Triple Intragastric Balloon 16
3.3 Related Markets 17
3.3.1 Breast Implant Market 17
3.3.2 Dental Implant Market 17
3.3.3 Facial Implant Market 18
4 Market Outlook 18
4.1 Overview 18
4.2 PEST Analysis 20
4.3 Porter 5(Five) Forces 21
5 Market Characteristics 22
5.1 Evolution 22
5.2 DRO – Global Intragastric Balloon Market Dynamics 23
5.2.1 Drivers 23 Rise in the prevalence of obesity 23 Increase prevalence of chronic diseases 24 Increasing popularity of MI techniques 24 Increase in number of outpatient procedure 24
5.2.2 Opportunities 24 Emerging endo-bariatric technology for treating obesity 24 Increase healthcare spending 25 Rise in medical tourism 25
5.2.3 Restraints 26 High cost of intragastric balloon procedures 26 Alternative techniques for treatment of obesity 26 Complications and risk associated with spine surgeries 27 Stringent regulatory framework and labeling requirement 27 Poor reimbursement policies 28 Intense competition among vendors 28
5.2.4 DRO – Impact Analysis 28
5.2.5 Key Stakeholders 29
6 Types: Market Size and Analysis 31
6.1 Overview 31
6.2 Single Intragastric Balloon 33
6.2.1 Overview 33
6.3 Dual Intragastric Balloon 35
6.3.1 Overview 35
6.4 Triple Intragastric Balloon 36
6.4.1 Overview 36
7 End User: Market Size and Analysis 38
7.1 Overview 38
7.2 Bariatric Surgical Centers 39
7.3 Ambulatory Surgical Care 39
7.4 Hospitals 40
8 Regions: Market Size and Analysis 42
8.1 Overview 42
8.2 North America 44
8.2.1 Market Overview 44
8.3 Europe 45
8.3.1 Market Overview 46
8.4 APAC 47
8.4.1 Market Overview 48
8.5 Rest of the World 49
8.5.1 Market Overview 50
9 Competitive Landscape 53
9.1 Overview 53
10 Vendor Profiles 53
10.1 Apollo Endosurgery, Inc. 53
10.1.1 Overview 53
10.1.2 Business Unit 55
10.1.3 Geographic Presence 56
10.1.4 Business Focus 57
10.1.5 SWOT Analysis 57
10.1.6 Business Strategy 58
10.2.1 Overview 59
10.2.2 Business Focus 60
10.2.3 SWOT Analysis 60
10.2.4 Business Strategy 61
10.3 Spatz FGIA, Inc. 62
10.3.1 Overview 62
10.4 ReShape Medical Inc. 63
10.4.1 Overview 63

Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players.
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports